168x Filetype PPTX File size 0.22 MB Source: sicsb.stemcell.conference.unair.ac.id
Introduction •Clinical studies showed potential of Stem Cell based therapy in the treatment of some degenerative, autoimmune and genetic disorders. •However, application of stem cell based therapy raises some ethical and safety issues •In Indonesia, many unproven “treatment” and direct- to-customer marketing of different (non human) stem cell interventions were offered in many ways Ethical Challenges of h-ESC •human embryonic stem cell (h-ESC) research has a major ethical dilemma, since it may be started with destruction of early human embryo. •The pluripotency of h-ESC may generate many different cell types, including teratomas and Risk to get Parkinson Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15 Ethical Challenges of i-PSC •Research and Clinical Application of Induced Pluripotent Stem Cell (i-PSC) are considered morally better than h-ESC, since it does not require destruction of human embryo •Risk of potential exploitation of created embryo, and risk of change natural reproduction including the possibility to derive gametes for same-sex reproduction, as well as in the asexual-reproduction •Risk of transformation in to tumor cells Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15 Ethical Challenges of MSC •Mesenchymal Stem Cell (MSC) can differentiate into a variety of cell types of mesodermal origin and neuro-ectodermal (neurons, astrocytes, and oligodendrocytes) or endodermal (hepatocytes) origin •MSC may promote tumor growth and metastasis, vision loss, detached retina Volarevic et al. Int. J. Med. Sci. 2018, Vol. 15 Regulation in Indonesia •The Law No 36 of 2009 regarding Health: •Research and clinical application of Human Embryonic Stem Cell (h-ESC) is not allowed •Cell transplantation, either from human or animal origin, may be applied only if its safety and benefits were approved •Stem Cell for reproduction of human being is forbidden
no reviews yet
Please Login to review.